{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:29:00Z","timestamp":1792121340881,"version":"4.4.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1007\/s00262-012-1292-7","type":"journal-article","created":{"date-parts":[[2012,6,8]],"date-time":"2012-06-08T09:19:45Z","timestamp":1339147185000},"page":"1485-1492","source":"Crossref","is-referenced-by-count":80,"title":["A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions"],"prefix":"10.1007","volume":"61","author":[{"given":"Peggy J.","family":"de Vos van Steenwijk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara H.","family":"Ramwadhdoebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margriet J. G.","family":"L\u00f6wik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline E.","family":"van der Minne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorien M. A.","family":"Berends-van der Meer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine M.","family":"Fathers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Rob P. M.","family":"Valentijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap","family":"Oostendorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert Jan","family":"Fleuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart W. J.","family":"Hellebrekers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marij J. P.","family":"Welters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariette I.","family":"van Poelgeest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis J. M.","family":"Melief","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma G.","family":"Kenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sjoerd H.","family":"van der Burg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,6,9]]},"reference":[{"key":"1292_CR1","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ijc.22527","volume":"121","author":"JS Smith","year":"2007","unstructured":"Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, Clifford GM (2007) Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 121:621\u2013632","journal-title":"Int J Cancer"},{"key":"1292_CR2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/oxfordjournals.jncimonographs.a003476","volume":"31","author":"M Schiffman","year":"2003","unstructured":"Schiffman M, Kjaer SK (2003) Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia. J Natl Cancer Inst Monogr 31:14\u201319","journal-title":"J Natl Cancer Inst Monogr"},{"key":"1292_CR3","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/j.1471-0528.1992.tb13704.x","volume":"99","author":"JB Murdoch","year":"1992","unstructured":"Murdoch JB, Morgan PR, Lopes A, Monaghan JM (1992) Histological incomplete excision of CIN after large loop excision of the transformation zone (LLETZ) merits careful follow up, not retreatment. Br J Obstet Gynaecol 99:990\u2013993","journal-title":"Br J Obstet Gynaecol"},{"key":"1292_CR4","doi-asserted-by":"crossref","first-page":"8056","DOI":"10.1128\/JVI.68.12.8056-8063.1994","volume":"68","author":"M Matloubian","year":"1994","unstructured":"Matloubian M, Concepcion RJ, Ahmed R (1994) CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J Virol 68:8056\u20138063","journal-title":"J Virol"},{"key":"1292_CR5","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0952-7915(98)80119-2","volume":"10","author":"AJ Zajac","year":"1998","unstructured":"Zajac AJ, Murali-Krishna K, Blattman JN, Ahmed R (1998) Therapeutic vaccination against chronic viral infection: the importance of cooperation between CD4+ and CD8+ T cells. Curr Opin Immunol 10:444\u2013449","journal-title":"Curr Opin Immunol"},{"key":"1292_CR6","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1086\/513992","volume":"175","author":"M Nakagawa","year":"1997","unstructured":"Nakagawa M, Stites DP, Farhat S, Sisler JR, Moss B, Kong F, Moscicki AB, Palefsky JM (1997) Cytotoxic T lymphocyte responses to E6 and E7 proteins of human papillomavirus type 16: relationship to cervical intraepithelial neoplasia. J Infect Dis 175:927\u2013931","journal-title":"J Infect Dis"},{"key":"1292_CR7","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1086\/315706","volume":"182","author":"M Nakagawa","year":"2000","unstructured":"Nakagawa M, Stites DP, Patel S, Farhat S, Scott M, Hills NK, Palefsky JM, Moscicki AB (2000) Persistence of human papillomavirus type 16 infection is associated with lack of cytotoxic T lymphocyte response to the E6 antigens. J Infect Dis 182:595\u2013598","journal-title":"J Infect Dis"},{"key":"1292_CR8","first-page":"472","volume":"62","author":"A Jong de","year":"2002","unstructured":"de Jong A, van der Burg SH, Kwappenberg KM, van der Hulst JM, Franken KL, Geluk A, van Meijgaarden KE, Drijfhout JW, Kenter G, Vermeij P, Melief CJ, Offringa R (2002) Frequent detection of human papillomavirus 16 E2-specific T-helper immunity in healthy subjects. Cancer Res 62:472\u2013479","journal-title":"Cancer Res"},{"key":"1292_CR9","first-page":"636","volume":"63","author":"MJ Welters","year":"2003","unstructured":"Welters MJ, de Jong A, van den Eeden SJ, van der Hulst JM, Kwappenberg KM, Hassane S, Franken KL, Drijfhout JW, Fleuren GJ, Kenter G, Melief CJ, Offringa R, van der Burg SH (2003) Frequent display of human papillomavirus type 16 E6-specific memory t-Helper cells in the healthy population as witness of previous viral encounter. Cancer Res 63:636\u2013641","journal-title":"Cancer Res"},{"key":"1292_CR10","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.1158\/0008-5472.CAN-04-0831","volume":"64","author":"A Jong de","year":"2004","unstructured":"de Jong A, van Poelgeest MI, van der Hulst JM, Drijfhout JW, Fleuren GJ, Melief CJ, Kenter G, Offringa R, van der Burg SH (2004) Human papillomavirus type 16-positive cervical cancer is associated with impaired CD4+ T-cell immunity against early antigens E2 and E6. Cancer Res 64:5449\u20135455","journal-title":"Cancer Res"},{"issue":"Pt 9","key":"1292_CR11","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1099\/0022-1317-80-9-2453","volume":"80","author":"HJ Bontkes","year":"1999","unstructured":"Bontkes HJ, de Gruijl TD, Bijl A, Verheijen RH, Meijer CJ, Scheper RJ, Stern PL, Burns JE, Maitland NJ, Walboomers JM (1999) Human papillomavirus type 16 E2-specific T-helper lymphocyte responses in patients with cervical intraepithelial neoplasia. J Gen Virol 80(Pt 9):2453\u20132459","journal-title":"J Gen Virol"},{"key":"1292_CR12","first-page":"4855","volume":"57","author":"M Nimako","year":"1997","unstructured":"Nimako M, Fiander AN, Wilkinson GW, Borysiewicz LK, Man S (1997) Human papillomavirus-specific cytotoxic T lymphocytes in patients with cervical intraepithelial neoplasia grade III. Cancer Res 57:4855\u20134861","journal-title":"Cancer Res"},{"key":"1292_CR13","doi-asserted-by":"crossref","first-page":"7188","DOI":"10.1158\/1078-0432.CCR-08-0994","volume":"14","author":"PJ de Vos van Steenwijk","year":"2008","unstructured":"de Vos van Steenwijk PJ, Piersma SJ, Welters MJ, van der Hulst JM, Fleuren G, Hellebrekers BW, Kenter GG, van der Burg SH (2008) Surgery followed by persistence of high-grade squamous intraepithelial lesions is associated with the induction of a dysfunctional HPV16-specific T-cell response. Clin Cancer Res 14:7188\u20137195","journal-title":"Clin Cancer Res"},{"key":"1292_CR14","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/sj.bjc.6605611","volume":"102","author":"S Daayana","year":"2010","unstructured":"Daayana S, Elkord E, Winters U, Pawlita M, Roden R, Stern PL, Kitchener HC (2010) Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia. Br J Cancer 102:1129\u20131136","journal-title":"Br J Cancer"},{"key":"1292_CR15","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa0810097","volume":"361","author":"GG Kenter","year":"2009","unstructured":"Kenter GG, Welters MJ, Valentijn AR, Lowik MJ, Berends-van der Meer DM, Vloon AP, Essahsah F, Fathers LM, Offringa R, Drijfhout JW, Wafelman AR, Oostendorp J, Fleuren GJ, van der Burg SH, Melief CJ (2009) Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia. N Engl J Med 361:1838\u20131847","journal-title":"N Engl J Med"},{"key":"1292_CR16","doi-asserted-by":"crossref","first-page":"11895","DOI":"10.1073\/pnas.1006500107","volume":"107","author":"MJ Welters","year":"2010","unstructured":"Welters MJ, Kenter GG, de Vos van Steenwijk PJ, Lowik MJ, Berends-van der Meer DM, Essahsah F, Stynenbosch LF, Vloon AP, Ramwadhdoebe TH, Piersma SJ, van der Hulst JM, Valentijn AR, Fathers LM, Drijfhout JW, Franken KL, Oostendorp J, Fleuren GJ, Melief CJ, van der Burg SH (2010) Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses. Proc Natl Acad Sci USA 107:11895\u201311899","journal-title":"Proc Natl Acad Sci USA"},{"key":"1292_CR17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0166-0934(93)90038-S","volume":"42","author":"LM Tieben","year":"1993","unstructured":"Tieben LM, ter Schegget J, Minnaar RP, Bouwes Bavinck JN, Berkhout RJ, Vermeer BJ, Jebbink MF, Smits HL (1993) Detection of cutaneous and genital HPV types in clinical samples by PCR using consensus primers. J Virol Methods 42:265\u2013279","journal-title":"J Virol Methods"},{"issue":"Pt 4","key":"1292_CR18","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1099\/0022-1317-76-4-1057","volume":"76","author":"AM Roda Husman","year":"1995","unstructured":"Roda Husman AM, Walboomers JM, Van Den Brule AJ, Meijer CJ, Snijders PJ (1995) The use of general primers GP5 and GP6 elongated at their 3\u2032 ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 76(Pt 4):1057\u20131062","journal-title":"J Gen Virol"},{"key":"1292_CR19","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1128\/JCM.40.3.779-787.2002","volume":"40","author":"AJ Brule Van Den","year":"2002","unstructured":"Van Den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJ, Snijders PJ (2002) GP5+\/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 40:779\u2013787","journal-title":"J Clin Microbiol"},{"key":"1292_CR20","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1158\/1078-0432.CCR-07-1881","volume":"14","author":"GG Kenter","year":"2008","unstructured":"Kenter GG, Welters MJ, Valentijn AR, Lowik MJ, Berends-van der Meer DM, Vloon AP, Drijfhout JW, Wafelman AR, Oostendorp J, Fleuren GJ, Offringa R, van der Burg SH, Melief CJ (2008) Phase I immunotherapeutic trial with long peptides spanning the E6 and E7 sequences of high-risk human papillomavirus 16 in end-stage cervical cancer patients shows low toxicity and robust immunogenicity. Clin Cancer Res 14:169\u2013177","journal-title":"Clin Cancer Res"},{"key":"1292_CR21","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1158\/1078-0432.CCR-07-1880","volume":"14","author":"MJ Welters","year":"2008","unstructured":"Welters MJ, Kenter GG, Piersma SJ, Vloon AP, Lowik MJ, Berends-van der Meer DM, Drijfhout JW, Valentijn AR, Wafelman AR, Oostendorp J, Fleuren GJ, Offringa R, Melief CJ, van der Burg SH (2008) Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine. Clin Cancer Res 14:178\u2013187","journal-title":"Clin Cancer Res"},{"key":"1292_CR22","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1158\/1078-0432.CCR-08-2227","volume":"15","author":"FM Speetjens","year":"2009","unstructured":"Speetjens FM, Kuppen PJ, Welters MJ, Essahsah F, Voet van den Brink AM, Lantrua MG, Valentijn AR, Oostendorp J, Fathers LM, Nijman HW, Drijfhout JW, van de Velde CJ, Melief CJ, van der Burg SH (2009) Induction of p53-specific immunity by a p53 synthetic long peptide vaccine in patients treated for metastatic colorectal cancer. Clin Cancer Res 15:1086\u20131095","journal-title":"Clin Cancer Res"},{"key":"1292_CR23","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00262-007-0378-0","volume":"57","author":"CM Britten","year":"2008","unstructured":"Britten CM, Gouttefangeas C, Welters MJ, Pawelec G, Koch S, Ottensmeier C, Mander A, Walter S, Paschen A, Muller-Berghaus J, Haas I, Mackensen A, Kollgaard T, Thor SP, Schmitt M, Giannopoulos K, Maier R, Veelken H, Bertinetti C, Konur A, Huber C, Stevanovic S, Wolfel T, van der Burg SH (2008) The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays. Cancer Immunol Immunother 57:289\u2013302","journal-title":"Cancer Immunol Immunother"},{"key":"1292_CR24","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1007\/s00262-010-0875-4","volume":"59","author":"Z Moodie","year":"2010","unstructured":"Moodie Z, Price L, Gouttefangeas C, Mander A, Janetzki S, Lower M, Welters MJ, Ottensmeier C, van der Burg SH, Britten CM (2010) Response definition criteria for ELISPOT assays revisited. Cancer Immunol Immunother 59:1489\u20131501","journal-title":"Cancer Immunol Immunother"},{"key":"1292_CR25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00262-010-0940-z","volume":"60","author":"CM Britten","year":"2011","unstructured":"Britten CM, Janetzki S, van der Burg SH, Huber C, Kalos M, Levitsky HI, Maecker HT, Melief CJ, O\u2019Donnell-Tormey J, Odunsi K, Old LJ, Pawelec G, Roep BO, Romero P, Hoos A, Davis MM (2011) Minimal information about T cell assays: the process of reaching the community of T cell immunologists in cancer and beyond. Cancer Immunol Immunother 60:15\u201322","journal-title":"Cancer Immunol Immunother"},{"key":"1292_CR26","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/ijc.23502","volume":"123","author":"M Hende van den","year":"2008","unstructured":"van den Hende M, van Poelgeest MI, van der Hulst JM, de Jong J, Drijfhout JW, Fleuren GJ, Valentijn AR, Wafelman AR, Slappendel GM, Melief CJ, Offringa R, van der Burg SH, Kenter GG (2008) Skin reactions to human papillomavirus (HPV) 16 specific antigens intradermally injected in healthy subjects and patients with cervical neoplasia. Int J Cancer 123:146\u2013152","journal-title":"Int J Cancer"},{"key":"1292_CR27","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.vaccine.2004.05.013","volume":"23","author":"IH Frazer","year":"2004","unstructured":"Frazer IH, Quinn M, Nicklin JL, Tan J, Perrin LC, Ng P, O\u2019Connor VM, White O, Wendt N, Martin J, Crowley JM, Edwards SJ, McKenzie AW, Mitchell SV, Maher DW, Pearse MJ, Basser RL (2004) Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX adjuvant in women with cervical intraepithelial neoplasia. Vaccine 23:172\u2013181","journal-title":"Vaccine"},{"key":"1292_CR28","doi-asserted-by":"crossref","first-page":"169e1","DOI":"10.1016\/j.ajog.2010.09.020","volume":"204","author":"JL Brun","year":"2011","unstructured":"Brun JL, Dalstein V, Leveque J, Mathevet P, Raulic P, Baldauf JJ, Scholl S, Huynh B, Douvier S, Riethmuller D, Clavel C, Birembaut P, Calenda V, Baudin M, Bory JP (2011) Regression of high-grade cervical intraepithelial neoplasia with TG4001 targeted immunotherapy. Am J Obstet Gynecol 204:169e1\u2013169e8","journal-title":"Am J Obstet Gynecol"},{"key":"1292_CR29","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.ygyno.2005.02.012","volume":"97","author":"M Seters van","year":"2005","unstructured":"van Seters M, van Beuren M, de Craen AJ (2005) Is the assumed natural history of vulvar intraepithelial neoplasia III based on enough evidence? A systematic review of 3322 published patients. Gynecol Oncol 97:645\u2013651","journal-title":"Gynecol Oncol"},{"key":"1292_CR30","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cellimm.2011.04.005","volume":"270","author":"M Matijevic","year":"2011","unstructured":"Matijevic M, Hedley ML, Urban RG, Chicz RM, Lajoie C, Luby TM (2011) Immunization with a poly (lactide co-glycolide) encapsulated plasmid DNA expressing antigenic regions of HPV 16 and 18 results in an increase in the precursor frequency of T cells that respond to epitopes from HPV 16, 18, 6 and 11. Cell Immunol 270:62\u201369","journal-title":"Cell Immunol"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-012-1292-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T13:13:01Z","timestamp":1594213981000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-012-1292-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,9]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["1292"],"URL":"https:\/\/doi.org\/10.1007\/s00262-012-1292-7","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.720882163.793559557","asserted-by":"object"}]},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,9]]}}}